Ivasyk Iryna, Morgenstern Peter F, Wembacher-Schroeder Eva, Souweidane Mark M
Department of Neurological Surgery, NewYork-Presbyterian Hospital, Weill Cornell Medicine.
Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York; and.
J Neurosurg Pediatr. 2017 Sep;20(3):256-260. doi: 10.3171/2017.5.PEDS1774. Epub 2017 Jul 7.
Convection-enhanced delivery (CED) uses positive pressure to induce convective flow of molecules and maximize drug distribution. Concerns have been raised about the effect of cystic structures on uniform drug distribution with CED. The authors describe the case of a patient with a diffuse intrinsic pontine glioma (DIPG) with a large cyst and examine its effect on drug distribution after CED with a radiolabeled antibody. The patient was treated according to protocol with CED of I-8H9 to the pons for nonprogressive DIPG after radiation therapy as part of a Phase I trial (clinical trial registration no. NCT01502917, clinicaltrials.gov). Care was taken to avoid the cystic cavity in the planned catheter track and target point. Co-infusion with Gd-DTPA was performed to assess drug distribution. Infusate distribution was examined by MRI immediately following infusion and analyzed using iPlan Flow software. Analysis of postinfusion MR images demonstrated convective distribution around the catheter tip and an elongated configuration of drug distribution, consistent with the superoinferior corticospinal fiber orientation in the brainstem. This indicates that the catheter was functioning and a pressure gradient was established. No infusate entry into the cystic region could be identified on T2-weighted FLAIR or T1-weighted images. The effects of ependymal and pial surfaces on drug delivery using CED in brainstem tumors remain controversial. Drug distribution is a critical component of effective application of CED to neurosurgical lesions. This case suggests that cyst cavities may not always behave as fluid "sinks" for drug distribution. The authors observed that infusate was not lost into the cyst cavity, suggesting that lesions with cystic components can be treated by CED without significant alterations to target and infusion planning.
对流增强递送(CED)利用正压诱导分子的对流流动并使药物分布最大化。人们对囊性结构对CED药物均匀分布的影响表示担忧。作者描述了一例患有弥漫性脑桥内生胶质瘤(DIPG)并伴有大囊肿的患者的病例,并研究了用放射性标记抗体进行CED后囊肿对药物分布的影响。该患者作为I期试验的一部分(临床试验注册号:NCT01502917,clinicaltrials.gov),在放射治疗后按照方案接受了向脑桥注入I-8H9进行CED治疗,用于非进展性DIPG。在规划导管路径和靶点时小心避开囊腔。同时注入钆喷酸葡胺(Gd-DTPA)以评估药物分布。注入后立即通过MRI检查注入物分布,并使用iPlan Flow软件进行分析。注入后MR图像分析显示导管尖端周围有对流分布,药物分布呈细长形,与脑干中皮质脊髓纤维的上下方向一致。这表明导管在起作用且建立了压力梯度。在T2加权液体衰减反转恢复(FLAIR)或T1加权图像上未发现注入物进入囊性区域。室管膜和软脑膜表面对脑干肿瘤使用CED进行药物递送的影响仍存在争议。药物分布是CED有效应用于神经外科病变的关键组成部分。该病例表明,囊腔可能并不总是表现为药物分布的液体“汇”。作者观察到注入物未进入囊腔,这表明具有囊性成分的病变可以通过CED进行治疗,而无需对靶点和注入计划进行重大改变。